Trivarx Ltd has released a press release.
Update on Breakthrough Device Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Global Master License & Services Agreement with Compass
- AGM Presentation
- MEB Signs Clinical Trial Agreement with MedBridge Healthcare
- Request For FDA Breakthrough Device Designation Submitted
- Patent Granted to Monitor Stress Conditions Using Heartrate
Later from TrivarX
- US FDA advises further data needed for MEBsleep approval
- Consumer Mental Health App Initial testing phase commenced
- Medibio Granted CE Mark Approval for MEBsleep
- MEB to Raise up to $3.5m By Way of a Placement and SPP
- Underwritten Share Purchase Plan Update
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX